MONDAY, June 7, 2021 (HealthDay Information) — Hospitalized sufferers with energetic cancer usually tend to die from COVID-19 than those that’ve survived most cancers and sufferers who’ve by no means had most cancers, a brand new research exhibits.
Researchers analyzed the information of almost 4,200 sufferers hospitalized at NYU Langone Medical Middle in New York Metropolis who examined optimistic for SARS-CoV-2, the virus that causes COVID-19. Of these sufferers, 233 had an energetic cancer diagnosis.
In-hospital charges of loss of life from COVID-19 have been about 34% amongst these with energetic most cancers however fell to about 28% amongst these with a historical past of most cancers or with no historical past of most cancers, the research discovered.
These with energetic blood cancers had the very best threat of loss of life from COVID-19, based on the research printed not too long ago within the journal Most cancers.
Receiving anti-cancer remedy — together with chemotherapy, molecularly targeted therapies and immunotherapy — inside three months earlier than hospitalization was not linked to a better threat of loss of life, the researchers stated.
“Amongst these hospitalized with energetic most cancers and COVID-19, current most cancers remedy was not related to worse outcomes,” stated research senior creator Dr. Daniel Becker, a medical oncologist at NYU Langone.
Due to this fact, “folks with energetic most cancers ought to take precautions in opposition to getting COVID-19, together with vaccination, however needn’t keep away from remedy for most cancers,” Becker stated in a journal information launch.
The findings additionally spotlight the significance of COVID-19 vaccination for most cancers sufferers, based on the journal’s incoming editor-in-chief, Dr. Suresh Ramalingam. He is deputy director of the Winship Most cancers Institute at Emory College in Atlanta and assistant dean for most cancers analysis on the college’s Faculty of Medication.
The U.S. Nationwide Most cancers Institute has extra on cancer patients and COVID-19.
SOURCE: Most cancers, information launch, June 7, 2021